Acetylation of PPARγ at K268/K293 increases atherosclerosis through upregulating ABCA1, ABCG1, and NcoR but inhibiting PRDM16, while deacetylation of PPARγ at K268 and K293 alleviates atherosclerosis. Here, PRDM16 is linked to atherosclerosis.